These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Upregulated long noncoding RNA LINC01296 indicates a dismal prognosis for pancreatic ductal adenocarcinoma and promotes cell metastatic properties by affecting EMT. Yuan Q, Zhang Y, Feng L, Jiang Y. J Cell Biochem; 2019 Jan; 120(1):552-561. PubMed ID: 30203487 [Abstract] [Full Text] [Related]
3. Tumor-derived exosomal lnc-Sox2ot promotes EMT and stemness by acting as a ceRNA in pancreatic ductal adenocarcinoma. Li Z, Jiang P, Li J, Peng M, Zhao X, Zhang X, Chen K, Zhang Y, Liu H, Gan L, Bi H, Zhen P, Zhu J, Li X. Oncogene; 2018 Jul; 37(28):3822-3838. PubMed ID: 29643475 [Abstract] [Full Text] [Related]
5. DNA Methylation Mediates EMT Gene Expression in Human Pancreatic Ductal Adenocarcinoma Cell Lines. Urbanova M, Buocikova V, Trnkova L, Strapcova S, Kajabova VH, Melian EB, Novisedlakova M, Tomas M, Dubovan P, Earl J, Bizik J, Svastova E, Ciernikova S, Smolkova B. Int J Mol Sci; 2022 Feb 14; 23(4):. PubMed ID: 35216235 [Abstract] [Full Text] [Related]
6. CCL18 promotes epithelial-mesenchymal transition, invasion and migration of pancreatic cancer cells in pancreatic ductal adenocarcinoma. Meng F, Li W, Li C, Gao Z, Guo K, Song S. Int J Oncol; 2015 Mar 14; 46(3):1109-20. PubMed ID: 25502147 [Abstract] [Full Text] [Related]
8. Involvement of epithelial to mesenchymal transition in the development of pancreatic ductal adenocarcinoma. Satoh K, Hamada S, Shimosegawa T. J Gastroenterol; 2015 Feb 14; 50(2):140-6. PubMed ID: 25216997 [Abstract] [Full Text] [Related]
9. BACH1 Promotes Pancreatic Cancer Metastasis by Repressing Epithelial Genes and Enhancing Epithelial-Mesenchymal Transition. Sato M, Matsumoto M, Saiki Y, Alam M, Nishizawa H, Rokugo M, Brydun A, Yamada S, Kaneko MK, Funayama R, Ito M, Kato Y, Nakayama K, Unno M, Igarashi K. Cancer Res; 2020 Mar 15; 80(6):1279-1292. PubMed ID: 31919242 [Abstract] [Full Text] [Related]
10. The involvement of lncRNAs in the development and progression of pancreatic cancer. Duguang L, Jin H, Xiaowei Q, Peng X, Xiaodong W, Zhennan L, Jianjun Q, Jie Y. Cancer Biol Ther; 2017 Dec 02; 18(12):927-936. PubMed ID: 29053398 [Abstract] [Full Text] [Related]
11. The role of epithelial-mesenchymal transition and autophagy in pancreatic ductal adenocarcinoma invasion. Yang J, Liu Y, Liu S. Cell Death Dis; 2023 Aug 07; 14(8):506. PubMed ID: 37550301 [Abstract] [Full Text] [Related]
12. Hypermethylation-mediated silencing of NDRG4 promotes pancreatic ductal adenocarcinoma by regulating mitochondrial function. Shi HH, Liu HE, Luo XJ. BMB Rep; 2020 Dec 07; 53(12):658-663. PubMed ID: 33298240 [Abstract] [Full Text] [Related]
13. CCR7 regulates Twist to induce the epithelial-mesenchymal transition in pancreatic ductal adenocarcinoma. Li K, Xu B, Xu G, Liu R. Tumour Biol; 2016 Jan 07; 37(1):419-24. PubMed ID: 26219899 [Abstract] [Full Text] [Related]
14. Epigenetic control of epithelial-to-mesenchymal transition and cancer metastasis. Wang Y, Shang Y. Exp Cell Res; 2013 Jan 15; 319(2):160-9. PubMed ID: 22935683 [Abstract] [Full Text] [Related]
15. H19 promotes pancreatic cancer metastasis by derepressing let-7's suppression on its target HMGA2-mediated EMT. Ma C, Nong K, Zhu H, Wang W, Huang X, Yuan Z, Ai K. Tumour Biol; 2014 Sep 15; 35(9):9163-9. PubMed ID: 24920070 [Abstract] [Full Text] [Related]
16. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma. Li DD, Fu ZQ, Lin Q, Zhou Y, Zhou QB, Li ZH, Tan LP, Chen RF, Liu YM. World J Gastroenterol; 2015 Aug 21; 21(31):9348-57. PubMed ID: 26309360 [Abstract] [Full Text] [Related]